Chlorophyllin attenuates IFN-γ expression in lipopolysaccharide- stimulated murine splenic mononuclear cells via suppressing IL-12 production

International Immunopharmacology

Volumn 5, Issue 13-14, 2005, Pages 1926-1935

  Yun, Cheol Heui ^a   Son, Chang Gue ^b   Chung, Dae Kyun ^c,d   Han, Seung Hyun ^a,e  

^a International Vaccine Institute   (South Korea)

^b Daejeon University   (South Korea)

^c Kyung Hee University   (South Korea)

^d RNA Inc   (South Korea)

^e Seoul National University   (South Korea)

Author keywords

Chlorophyllin; Immunosuppression; Interferon gamma; Interleukin 12; Lipopolysaccharide; Splenocytes

Indexed keywords

CHLOROPHYLL; FAS LIGAND; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12 RECEPTOR; INTERLEUKIN 12 RECEPTOR BETA2; INTERLEUKIN 12P40; LIPOPOLYSACCHARIDE; MESSENGER RNA; PROTEIN P35; PROTEIN P70; RECOMBINANT INTERLEUKIN 12; STAT3 PROTEIN; STAT4 PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL ACTIVATION; CYTOKINE PRODUCTION; DNA BINDING; DNA BINDING MOTIF; DOSE RESPONSE; DOWN REGULATION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GEL MOBILITY SHIFT ASSAY; IMMUNOSUPPRESSIVE TREATMENT; MONONUCLEAR CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA PROCESSING; RODENT DISEASE; SPLEEN CELL; TRANSCRIPTION INITIATION;

ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; CHLOROPHYLLIDES; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-12 SUBUNIT P40; LIPOPOLYSACCHARIDES; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MONOCYTES; NF-KAPPA B; PROTEIN SUBUNITS; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-12; RNA, MESSENGER; SPLEEN; STAT3 TRANSCRIPTION FACTOR; STAT4 TRANSCRIPTION FACTOR; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 27744566553     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.06.014     Document Type: Article

References (43)

1. U. Boehm, T. Klamp, M. Groot, and J.C. Howard Cellular responses to interferon-gamma Annu Rev Immunol 15 1997 749 795
2. M.F. Gruber, and T.L. Gerrard Production of macrophage colony-stimulating factor (M-CSF) by human monocytes is differentially regulated by GM-CSF, TNF alpha, and IFN-gamma Cell Immunol 142 2 1992 361 369
3. H. de Wit, W.H. Dokter, M.T. Esselink, M.R. Halie, and E. Vellenga Interferon-gamma enhances the LPS-induced G-CSF gene expression in human adherent monocytes, which is regulated at transcriptional and posttranscriptional levels Exp Hematol 21 6 1993 785 790
4. M. Matsuura, S. Saito, Y. Hirai, and H. Okamura A pathway through interferon-gamma is the main pathway for induction of nitric oxide upon stimulation with bacterial lipopolysaccharide in mouse peritoneal cells Eur J Biochem 270 19 2003 4016 4025
5. H. Yssel, S. Fasler, J.E. de Vries, and R. de Waal Malefyt IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T cell clones Int Immunol 6 7 1994 1091 1096
6. H. Okamura, H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, and T. Tanimoto Cloning of a new cytokine that induces IFN-gamma production by T cells Nature 378 6552 1995 88 91
7. G.J. Bancroft, R.D. Schreiber, and E.R. Unanue Natural immunity: a T-cell-independent pathway of macrophage activation, defined in the scid mouse Immunol Rev 124 1991 5 24
8. S. Stoll, G. Muller, M. Kurimoto, J. Saloga, T. Tanimoto, and H. Yamauchi Production of IL-18 (IFN-gamma-inducing factor) messenger RNA and functional protein by murine keratinocytes J Immunol 159 1 1997 298 302
9. N. Udagawa, N.J. Horwood, J. Elliott, A. Mackay, J. Owens, and H. Okamura Interleukin-18 (interferon-gamma-inducing factor) is produced by osteoblasts and acts via granulocyte/macrophage colony-stimulating factor and not via interferon-gamma to inhibit osteoclast formation J Exp Med 185 6 1997 1005 1012
10. G. Monteleone, F. Trapasso, T. Parrello, L. Biancone, A. Stella, and R. Iuliano Bioactive IL-18 expression is up-regulated in Crohn's disease J Immunol 163 1 1999 143 147
11. F. Pages, A. Berger, B. Henglein, B. Piqueras, C. Danel, and F. Zinzindohoue Modulation of interleukin-18 expression in human colon carcinoma: consequences for tumor immune surveillance Int J Cancer 84 3 1999 326 330
12. R.H. Dashwood The importance of using pure chemicals in (anti) mutagenicity studies: chlorophyllin as a case in point Mutat Res 381 2 1997 283 286
13. T. Negishi, S. Arimoto, C. Nishizaki, and H. Hayatsu Inhibitory effect of chlorophyll on the genotoxicity of 3-amino-1-methyl-5H-pyrido[4,3-b]indole (Trp-P-2) Carcinogenesis 10 1 1989 145 149
14. S. Arimoto, T. Negishi, and H. Hayatsu Inhibitory effect of hemin on the mutagenic activities of carcinogens Cancer Lett 11 1 1980 29 33
15. Y. Katoh, N. Nemoto, M. Tanaka, and S. Takayama Inhibition of benzo[a]pyrene-induced mutagenesis in Chinese hamster V79 cells by hemin and related compounds Mutat Res 121 2 1983 153 157
16. T.W. Kensler, P.A. Egner, J.B. Wang, Y.R. Zhu, B.C. Zhang, and P.X. Lu Chemoprevention of hepatocellular carcinoma in aflatoxin endemic areas Gastroenterology 127 5 Suppl 1 2004 S310 S318
17. R.H. Dashwood, V. Breinholt, and G.S. Bailey Chemopreventive properties of chlorophyllin: inhibition of aflatoxin B1 (AFB1)-DNA binding in vivo and anti-mutagenic activity against AFB1 and two heterocyclic amines in the Salmonella mutagenicity assay Carcinogenesis 12 5 1991 939 942
18. S. Arimoto, S. Fukuoka, C. Itome, H. Nakano, H. Rai, and H. Hayatsu Binding of polycyclic planar mutagens to chlorophyllin resulting in inhibition of the mutagenic activity Mutat Res 287 2 1993 293 305
19. C.H. Yun, H.G. Jeong, J.W. Jhoun, and F.P. Guengerich Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes Carcinogenesis 16 6 1995 1437 1440
20. S.S. Kumar, B. Shankar, and K.B. Sainis Effect of chlorophyllin against oxidative stress in splenic lymphocytes in vitro and in vivo Biochim Biophys Acta 1672 2 2004 100 111
21. K.J. Cho, S.H. Han, B.Y. Kim, S.G. Hwang, K.K. Park, and K.H. Yang Chlorophyllin suppression of lipopolysaccharide-induced nitric oxide production in RAW 264.7 cells Toxicol Appl Pharmacol 166 2 2000 120 127
22. K.H. Yang, B.S. Kim, A.E. Munson, and M.P. Holsapple Immunosuppression induced by chemicals requiring metabolic activation in mixed cultures of rat hepatocytes and murine splenocytes Toxicol Appl Pharmacol 83 3 1986 420 429
23. G. Fantuzzi, D.A. Reed, and C.A. Dinarello IL-12-induced IFN-gamma is dependent on caspase-1 processing of the IL-18 precursor J Clin Invest 104 6 1999 761 767
24. H. Xiong, C. Zhu, F. Li, R. Hegazi, K. He, and M. Babyatsky Inhibition of interleukin-12 p40 transcription and NF-kappaB activation by nitric oxide in murine macrophages and dendritic cells J Biol Chem 279 11 2004 10776 10783
25. M. Lee, H.M. Kim, and K.H. Yang Down-regulation of protein kinase C in murine splenocytes: a potential mechanism for 2-acetylaminofluorene-mediated immunosuppression Cancer Lett 101 1 1996 53 57
26. H.R. Zhou, Z. Islam, and J.J. Pestka Kinetics of lipopolysaccharide- induced transcription factor activation/inactivation and relation to proinflammatory gene expression in the murine spleen Toxicol Appl Pharmacol 187 3 2003 147 161
27. S.H. Han, Y.J. Jeon, S.S. Yea, and K.H. Yang Suppression of the interleukin-2 gene expression by aflatoxin B1 is mediated through the down-regulation of the NF-AT and AP-1 transcription factors Toxicol Lett 108 1 1999 1 10
28. M.J. Micallef, T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, and M. Namba Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production Eur J Immunol 26 7 1996 1647 1651
29. K. Kohno, J. Kataoka, T. Ohtsuki, Y. Suemoto, I. Okamoto, and M. Usui IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12 J Immunol 158 4 1997 1541 1550
30. N.G. Jacobson, S.J. Szabo, R.M. Weber-Nordt, Z. Zhong, R.D. Schreiber, and J.E. Darnell Jr. Interleukin 12 signaling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat)3 and Stat4 J Exp Med 181 5 1995 1755 1762
31. A.S. Baldwin Jr. The NF-kappa B and I kappa B proteins: new discoveries and insights Annu Rev Immunol 14 1996 649 683
32. W.T. Watford, M. Moriguchi, A. Morinobu, and J.J. O'Shea The biology of IL-12: coordinating innate and adaptive immune responses Cytokine Growth Factor Rev 14 5 2003 361 368
33. G. Trinchieri Interleukin-12 and the regulation of innate resistance and adaptive immunity Nat Rev Immunol 3 2 2003 133 146
34. B.B. Desai, P.M. Quinn, A.G. Wolitzky, P.K. Mongini, R. Chizzonite, and M.K. Gately IL-12 receptor: II. Distribution and regulation of receptor expression J Immunol 148 10 1992 3125 3132
35. A.C. Mullen, F.A. High, A.S. Hutchins, H.W. Lee, A.V. Villarino, and D.M. Livingston Role of T-bet in commitment of TH1 cells before IL-12-dependent selection Science 292 5523 2001 1907 1910
36. C.S. Lankford, and D.M. Frucht A unique role for IL-23 in promoting cellular immunity J Leukoc Biol 73 1 2003 49 56
37. Kollet JI, Petro TM. IRF-1 and NF-kappaB p50/cRel bind to distinct regions of the proximal murine IL-12 p35 promoter during costimulation with IFN-gamma and LPS. Mol Immunol in press.
38. J. Liu, X. Guan, T. Tamura, K. Ozato, and X. Ma Synergistic activation of interleukin-12 p35 gene transcription by interferon regulatory factor-1 and interferon consensus sequence-binding protein J Biol Chem 279 53 2004 55609 55617
39. K. Takeda, and S. Akira STAT family of transcription factors in cytokine-mediated biological responses Cytokine Growth Factor Rev 11 3 2000 199 207
40. A.L. Wurster, T. Tanaka, and M.J. Grusby The biology of Stat4 and Stat6 Oncogene 19 21 2000 2577 2584
41. K. Kamezaki, K. Shimoda, A. Numata, T. Matsuda, K. Nakayama, and M. Harada The role of Tyk2, Stat1 and Stat4 in LPS-induced endotoxin signals Int Immunol 16 8 2004 1173 1179
42. L.M. Stamm, A.A. Satoskar, S.K. Ghosh, J.R. David, and A.R. Satoskar STAT-4 mediated IL-12 signaling pathway is critical for the development of protective immunity in cutaneous leishmaniasis Eur J Immunol 29 8 1999 2524 2529
43. M.E. Persky, K.M. Murphy, and J.D. Farrar IL-12, but not IFN-alpha, promotes STAT4 activation and Th1 development in murine CD4+ T cells expressing a chimeric murine/human Stat2 gene J Immunol 174 1 2005 294 301